Skip to main content
Premium Trial:

Request an Annual Quote

Allelica Raises $1.75M Seed Round, Moves Headquarters to US

This article has been changed from a previous version to update the names of Allelica's investors. 

NEW YORK – Allelica, a startup developer of software for polygenic risk scoring, has closed a $1.75 million round of seed funding. Valor Ventures, which led the round, announced the investment Thursday.

Other investors include Pi Campus, Sternberg Health, and several unspecified angel investors.

An Allelica spokesperson confirmed to GenomeWeb Thursday that the company is moving its headquarters from Rome to New York. Allelica CEO Giordano Bottà said in a statement that North America represents the firm's largest market.

As a result of the investment, Valor General Partner Gary Peat has joined the Allelica board of directors. The firm also has used some of the funding to hire Baltimore-based Edgar Carter as VP of sales. 

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.